TTR and familial amyloid neuropathy: Acoramidis (AG10) represents a newer approach to TTR stabilization, mimicking the structural stabilizing properties of the TTR variant p.T139M, which protects against familial amyloid polyneuropathy in heterozygous carriers of the disease-causing p.V50M variant [95,97].